What is the recommended administration schedule for the DTPa (Diphtheria, Tetanus, and Pertussis) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DTaP Vaccination Schedule

Children should receive DTaP vaccine in a five-dose series at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age. 1, 2

Standard Primary Series (Ages 2-6 Months)

  • Administer the first dose at 2 months of age (minimum age 6 weeks) 1, 2
  • Give the second dose at 4 months of age, with a minimum 4-week interval from the first dose if an accelerated schedule is needed 1, 2
  • Provide the third dose at 6 months of age, ensuring it is not given before 14 weeks of age 1, 2

Booster Doses

Fourth Dose (15-18 Months)

  • Administer at 15-18 months of age to maintain adequate immunity during preschool years 1, 2
  • May be given as early as 12 months if at least 6 months have elapsed since the third dose 1, 2
  • Must not be administered to children younger than 12 months 1, 2

Fifth Dose (4-6 Years)

  • Give at 4-6 years of age to confer continued protection during early school years 1, 2
  • This fifth dose is not necessary if the fourth dose was administered at age 4 years or older 1, 2

Critical Timing Requirements

  • The fourth dose requires a minimum 6-month interval after the third dose 1, 2
  • The third dose must not be given before 14 weeks of age regardless of intervals 1, 2
  • When using an accelerated schedule, maintain at least 4 weeks between doses 1 and 2 1

Common Pitfalls to Avoid

  • Invalid doses occur when the fourth dose is given before 12 months of age or less than 6 months after the third dose - these must be repeated 2
  • Children who receive the third dose late are at higher risk of missing or receiving the fourth dose late (24% vs 10% for on-time recipients) 3
  • While the same manufacturer's DTaP product should ideally be used throughout the series, vaccination should never be delayed if the previous brand is unavailable or unknown 1, 2

Adolescent Transition

  • At 11-12 years of age, adolescents who completed the childhood DTaP series should receive a single dose of Tdap (tetanus, diphtheria, acellular pertussis) vaccine 1
  • This replaces the previous recommendation for Td booster at 14-16 years 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

DTaP Vaccination Schedule for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Predictors of age-appropriate receipt of DTaP dose 4.

American journal of preventive medicine, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.